Expertise

After working in behavioral health for a decade and finding mental healthcare to be splintered and inaccessible for many patients, Ben founded Bespoke Treatment in 2019. Ben attended graduate school at Columbia University and received a Master of Science degree in Neuroscience and Education. During graduate school, Ben developed a specialty in clinical neuromodulation and neuroimaging, where he used brain scans to predict off-label uses for TMS, neurofeedback, and Ketamine. Ben’s research has been published in prestigious journals such as Brain Stimulation and ACR Open Rheumatology, and presented at The Clinical TMS Society, The International Neuropsychological Society, and the NYC Neuromodulation Conference. As a Cognitive Neuroscience Ph.D. candidate, Ben is currently researching ways to continue to personalize and optimize brain stimulation and medical psychedelic use.  Ben serves as the Psychedelic Medicine Association’s Chapter Head of the Neurology Special Interest Group and has been honored as a 2023 Future Leader Under 40 by Behavioral Health Business and a Top 10 CEO to watch out for by Entrepreneur.com. Ben prides himself in bringing together the special team of individuals that makes up Bespoke Treatment.